SEC Form 4 · accession 0001614671-15-000009
PREMIER BIOMEDICAL INC · BIEI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mitchell S Felder
Director · 10% Owner · Other
Period of report
Sep 8, 2015
Accepted (ET)
Sep 10, 2015 · 12:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001515740
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 8, 2015 | M | 1,000,000 | $0.00 | A | 4,453,944 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (right to buy)F1 | $0.00 | Sep 8, 2015 | M | 1,000,000 | D | Jun 21, 2010 | Jun 21, 2020 | Common Stock | 1,000,000 | 16,000,000 | D |
Explanation of responses
- F1The price was $0.00001 per share.